We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AVIR market cap is 311.51M. The company's latest EPS is USD -1.9676 and P/E is -1.84.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -46.57M | -69.81M | -46.92M | -37.2M | -39.03M |
| Net Income | -39.16M | -63.17M | -40.52M | -31.15M | -33.54M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 48.63M | 351.37M | 0 | 0 | 0 |
| Operating Income | -11.03M | 138.38M | -130.65M | -164.16M | -192.95M |
| Net Income | -10.95M | 121.19M | -116.59M | -135.96M | -168.39M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 594.97M | 553.03M | 510.38M | 490.96M | 464.67M |
| Total Liabilities | 39.78M | 48.66M | 33.91M | 32.44M | 25.8M |
| Total Equity | 555.19M | 504.37M | 476.47M | 458.52M | 438.87M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 863.63M | 772.89M | 666.71M | 594.97M | 464.67M |
| Total Liabilities | 315.83M | 62.82M | 26.14M | 39.78M | 25.8M |
| Total Equity | 547.8M | 710.08M | 640.57M | 555.19M | 438.87M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -85.4M | -39.87M | -82.07M | -105.1M | -135.5M |
| Investing | 40.3M | 56.8M | 181.49M | 59.48M | 56.11M |
| Financing | 257k | 150k | 150k | 267k | 267k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 296.73M | -87.01M | -120.98M | -85.4M | -135.5M |
| Investing | -26k | -4k | -455.41M | 40.3M | 56.11M |
| Financing | 531.75M | 1.47M | 370k | 257k | 267k |
| Market Cap | 311.51M |
| Price to Earnings Ratio | -1.84 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.8 |
| Price to Book Ratio | 0.71 |
| Dividend Yield | - |
| Shares Outstanding | 85.58M |
| Average Volume (1 week) | 452.36k |
| Average Volume (1 Month) | 413.17k |
| 52 Week Change | 11.66% |
| 52 Week High | 4.145 |
| 52 Week Low | 2.30 |
| Spread (Intraday) | 3.76 (50.81%) |
| Company Name | Atea Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ateapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
